Atavistik Bio
PrivateLast Round
Series B
Mar 5, 2026
Total Funding Raised
$460M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Atavistik Bio is a biopharmaceutical company that discovers and develops precision allosteric small molecule therapeutics for metabolic diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atavistik Bio Comparables
Compare Atavistik Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alterome Therapeutics | 88% | |
| HotSpot Therapeutics | 86% | |
| Frontier Medicines | 83% | |
Atavistik Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 5, 2026 | ||||
| Series B | Dec 18, 2025 | ||||
| Series A Extension | Dec 19, 2023 | ||||
| Series A | Aug 24, 2021 |
Key People
Founding team and executive leadership
Atavistik Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series A, Series A Extension |
| RA Capital Management | Series B |
| Lux Capital | Series A, Series B, Series A Extension |
| The Chernin Group | Series A, Series A Extension |
| Nextech Invest | Series A, Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Agent ZE74-0282 is currently in Phase I clinical trials.
- Mar 16, 2026
Advancing an allosteric JAK2 V617F inhibitor toward clinical proof of concept.
Atavistik Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atavistik Bio's valuation, stock price, and market status.